If you’ve had the opportunity to read my article on SARMs and their influence on testosterone levels, you may remember that I emphasized the significance of Suppression in LGD-4033. This specific SARM presents the potential for two unfavorable effects on users: significant testosterone suppression and unwanted water retention.
To gain a comprehensive understanding of the extent of suppression caused by LGD-4033, I strongly recommend exploring the complete article for in-depth insights.
Table of Contents 1. LGD-4033 Suppression Intensity 2. How Does LGD-4033 Suppression Feel Like 3. How To Mitigate LGD-4033 Suppression 4. Conclusion |
LGD-4033 Suppression Intensity
While some may face mild to severe suppression with Ligandrol, over 70% are likely to experience moderate suppression. Therefore, Ligandrol should not be underestimated, as its effects can be significant.
Although studies have shown that administering low doses of Ligandrol to human subjects has no adverse effects, the dosages commonly used by users often exceed 3mg per day. As a result, testosterone suppression becomes a legitimate concern, and with Ligandrol, it follows a dose-dependent pattern, meaning that higher dosages lead to more pronounced suppression.
How Does LGD-4033 Suppression Feel Like
Ligandrol may lead to symptoms of depression, reduced libido, and a bloated feeling due to water retention. It’s essential to take water retention seriously, as it can exacerbate depression and body image concerns.
To address water retention, maintaining proper hydration and following a healthy diet is advisable. Typically, suppression resulting from Ligandrol becomes noticeable around the five to six-week mark of a SARM cycle. During this phase, some individuals may struggle with motivation to go to the gym and may need to push themselves to maintain their fitness routine.
Depression is a significant and concerning issue associated with Ligandrol use, and it should not be underestimated.
Lowered libido strains relationships, compounded by low energy levels that bring extra difficulties. Let’s now explore strategies for mitigating the suppression caused by LGD-4033.
How To Mitigate LGD-4033 Suppression
Addressing the suppression induced by LGD-4033 can be a complex task with two primary options available: using Selective Estrogen Receptor Modulators (SERMs) or opting for a natural Post-Cycle Therapy (PCT).
It’s important to recognize that Ligandrol’s potency surpasses that of Ostarine, reducing the possibility of avoiding PCT when using this compound. For those interested in utilizing low-dose Ligandrol to minimize the need for PCT, I have authored an article titled “LGD-4033 with no PCT” that might provide valuable insights.
Realistically, Ligandrol dosages can vary from 5 to 20mg per day, making some degree of suppression almost inevitable. It is advisable to closely monitor your body’s response and act accordingly. For moderate suppression, consider a natural PCT; I offer a guide titled “Natural PCT for SARMs” on my website. However, if suppression is severe and worsening, SERMs like Nolvadex or Clomid may be the only viable recourse.
Conclusion
Mitigating the substantial suppression associated with LGD-4033 is of paramount importance, and exercising caution is key. One effective strategy involves reducing the dosage while implementing natural Post-Cycle Therapy (PCT). Based on my personal experience, a daily dosage of 10mg has proven to strike an optimal balance. This dosage permits substantial gains while maintaining suppression at a manageable level, typically falling within the mild to moderate range.